share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director WADDELL FREDERICK H

SEC announcement ·  May 7 18:31
Summary by Moomoo AI
On May 3, 2024, Frederick H. Waddell, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Waddell's direct holdings in the company increased to a total of 27,755 shares. The grant, which is part of the company's compensation or incentive program, reflects AbbVie's ongoing commitment to align the interests of its executives with those of its shareholders. The transaction was completed successfully, with no subsequent sales reported.
On May 3, 2024, Frederick H. Waddell, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Waddell's direct holdings in the company increased to a total of 27,755 shares. The grant, which is part of the company's compensation or incentive program, reflects AbbVie's ongoing commitment to align the interests of its executives with those of its shareholders. The transaction was completed successfully, with no subsequent sales reported.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more